𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Experimental grounds for using chlorin ρ6 in the photodynamic therapy of malignant tumors

✍ Scribed by G.A. Kostenich; I.N. Zhuravkin; E.A. Zhavrid


Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
684 KB
Volume
22
Category
Article
ISSN
1011-1344

No coin nor oath required. For personal study only.

✦ Synopsis


The toxicity, pharmacokinetics and antitumour effect of chlorin e6 after light irradiation were studied. The LD50 value of chlorin e6 in C3H mice is 189 +/- 9 mg kg-1 and in Wistar white rats is 113 +/- 18 mg kg-1 14 days after intraperitoneal injection. The concentration of chlorin e6 in blood, liver, kidney, spleen and tumors (sarcoma M-1 and sarcoma 45) of the rats was determined by a fluorescence method, 3, 6, 12, 18, 24, 48 and 72 h after administration at a dose of 10 mg kg-1. For this purpose, chlorin e6 was extracted from tissues by the detergent Triton X-100. The depth of necrosis in sarcoma 45, the regression rate of sarcoma M-1 and the animal cure rate were evaluated after chlorin e6 administration at doses of 1-10 mg kg-1 and subsequent irradiation with krypton laser light. Depending on the dose and the time interval between chlorin e6 injection and irradiation, the depth of necrosis in sarcoma 45 varied from 5.0 to 15.0 mm. The cure rate of the animals with sarcoma M-1 varied from 10% to 60%. The antitumor effect was directly proportional to the chlorin e6 dose and light energy exposure and inversely proportional to the time interval between photosensitizer injection and irradiation.


📜 SIMILAR VOLUMES


Photodynamic therapy using mTHPC for mal
✍ Kathleen F.M. Fan; Colin Hopper; Paul M. Speight; Giovanni A. Buonaccorsi; Steph 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 428 KB 👁 1 views

Photodynamic therapy (PDT) produces local tumor necrosis, on activation of a previously administered sensitizer with non-thermal light of an appropriate wavelength. It is attractive for treating tumors of the mouth as tissue healing is particularly good. We describe the use of the photosensitizing a

Localization of experimental submucosal
✍ Sheyhedin, Ilyar; Okunaka, Tetsuya; Kato, Harubumi; Yamamoto, Yutaka; Sakaniwa, 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

## Background and objective: To increase the applicability of photodynamic diagnosis with regard to deep-seated tumor, we illuminated tumors with a long-wavelength laser beam after photosensitization with mono-l-aspartyl chlorin e6 (npe6). ## Study design/materials and methods: Rabbits with vx2 e

The importance of In situ light dosimetr
✍ I. Bing Tan; Hugo Oppelaar; Marjan C. Ruevekamp; Ruth B. Veenhuizen; Adrian Timm 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

Background. Photodynamic therapy (PDT) is being evaluated for treatment of localized head and neck cancer. ''Light dose'' is usually prescribed as incident fluence, which takes no account of reflected and scattered light. This study investigates variations in total tissue fluence for a given inciden

Sensitizer for photodynamic therapy of c
✍ Q. Peng; J. Moan; M. Kongshaug; Jan F. Evensen; H. Anholt; C. Rimington 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 711 KB

## Abstract The distribution of Photofrin II (P‐II) and aluminum phthalocyanine tetrasulfonate (AIPCS~4~) in tissues of BALB/c nu/nu nude mice bearing the LOX human melanoma was measured fluorimetrically at different times after intraperitoneal injection of the drugs, 20 mg/kg body weight. The plas

Vaccination with tumor cell lysate-pulse
✍ Ryuta Saito; Masaaki Mizuno; Norimoto Nakahara; Takaya Tsuno; Toshihiro Kumabe; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 372 KB 👁 1 views

## Abstract Interferon‐β (IFN‐β) has been used as an antitumor drug against human glioma, melanoma and medulloblastoma since the 1980s. Recently, we developed a new gene therapy using the __IFN__‐β gene against malignant gliomas and then began clinical trials in 2000. Since stimulation of immune sy